![](/img/cover-not-exists.png)
Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?
Adam La CazeVolume:
23
Language:
english
Journal:
PharmacoEconomics
DOI:
10.2165/00019053-200523050-00004
Date:
May, 2005
File:
PDF, 62 KB
english, 2005